Pazopanib in renal cell carcinoma

Clin Adv Hematol Oncol. 2010 Apr;8(4):232-3.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Humans
  • Indazoles
  • Kidney Neoplasms / drug therapy*
  • Pyrimidines / adverse effects
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Sulfonamides / adverse effects
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib